Swara Baby’s ₹1,000 Crore IPO: Why Fresh Equity and an Offer for Sale Tell Different Stories

When a company announces a ₹1,000 crore IPO, the headline figure attracts attention.

But for anyone evaluating its financial position, the more useful questions are:

How much new capital will the company receive? How much will existing shareholders sell? How will the proceeds be used? And what will the company's balance sheet look like after the transaction?

Swara Baby Products offers a timely example.

The disposable hygiene products manufacturer received observations from the Securities and Exchange Board of India on 6 October 2026 for its proposed ₹1,000 crore initial public offering.

The proposed issue comprises up to ₹500 crore in fresh equity and up to ₹500 crore through an offer for sale.

The distinction is important because the two components have different implications for the company and its shareholders.

Fresh issue versus offer for sale

A fresh issue involves the company issuing new shares and receiving the proceeds, subject to the final issue structure and applicable expenses.

An offer for sale, or OFS, involves existing shareholders selling their shares. The proceeds from those sales go to the selling shareholders rather than the company.

This means an IPO with a ₹1,000 crore headline size does not necessarily provide the issuer with ₹1,000 crore of new capital.

In Swara Baby's proposed issue, the fresh issue is up to ₹500 crore. The OFS is also up to ₹500 crore.

That distinction matters when evaluating the potential effect on the company's financial position.

Fresh equity can fund capital expenditure, repay borrowings or support other stated corporate purposes. An OFS primarily changes the ownership of existing shares.

Neither structure is inherently better. Their implications depend on the company's funding needs, the purpose of the transaction and the objectives of the selling shareholders.

How Swara Baby proposes to use the fresh proceeds

The company's disclosed plans include allocating approximately ₹198.2 crore towards establishing a new manufacturing facility in Madhya Pradesh.

It also proposes to use ₹100 crore for repayment or prepayment of certain borrowings and ₹27.5 crore for investments in subsidiaries to repay or prepay their outstanding borrowings.

The remaining proceeds are intended for other stated purposes, including inorganic growth opportunities and general corporate purposes, subject to the final offer documents.

These allocations provide a useful starting point for understanding the proposed transaction.

Part of the fresh capital is intended to support expansion. Another portion is intended to reduce debt at the company or subsidiary level.

The credit implications of these uses can differ.

Capital expenditure may support future production capacity and revenue generation, but it also requires execution and funding before the expected benefits are realised.

Debt repayment may reduce outstanding borrowings and future interest obligations, depending on the debt being repaid and the terms of the transaction.

The overall outcome depends on the company's financial position before the IPO and how the proceeds are ultimately deployed.

Why debt repayment is only one part of the analysis

Repaying debt can strengthen a company's financial position, but the effect should not be evaluated in isolation.

Consider a company that uses a portion of fresh equity to repay borrowings while simultaneously undertaking substantial expansion.

Its outstanding debt may decline, but capital expenditure could increase its future funding requirements.

The company may also need additional working capital as production volumes and sales increase.

Consequently, a complete assessment should consider the post-transaction balance sheet, projected cash flows, remaining borrowings and future investment requirements.

The relevant question is not simply how much debt the company intends to repay.

It is whether the proposed capital structure will remain appropriate for the business's operating and funding needs.

Growth creates its own funding requirements

Swara Baby's proposed IPO combines debt repayment with investment in manufacturing capacity.

This highlights a common challenge for expanding businesses.

Growth requires capital before it necessarily produces additional cash.

A new facility may involve construction, equipment, recruitment, commissioning and initial working-capital requirements. Revenue contributions may emerge gradually as production and customer demand develop.

During that period, management needs to ensure that the company can meet existing obligations while funding its expansion plans.

For credit analysis, this means looking beyond expected revenue growth.

The timing of cash flows, the pace of capital expenditure, the funding mix and the company's ability to service its obligations during the investment phase all matter.

The business model matters too

Swara Baby operates in the contract manufacturing segment of disposable hygiene products, including baby diapers, adult incontinence products and feminine hygiene products.

According to the company's disclosed financial information, revenue from operations increased from approximately ₹943 crore in FY25 to ₹1,164 crore in FY26. Profit after tax increased from approximately ₹80.7 crore to ₹95.6 crore over the same period.

These figures provide context for the company's scale and recent financial performance.

However, historical growth alone cannot establish the future financial strength of the business.

For a contract manufacturer, factors such as customer relationships, order visibility, product mix, manufacturing utilisation, input costs and working-capital requirements can influence future earnings and cash generation.

A credit assessment therefore needs to examine both the financial results and the business risks underlying them.

What promoters and CFOs should examine before a fundraise

Swara Baby's proposed transaction illustrates several questions that other companies can use when evaluating an equity raise.

1. What proportion of the issue provides new capital?

The distinction between fresh issuance and an OFS should be clear from the outset.

The headline size of the offering is not the same as the amount of capital entering the business.

2. How will the proceeds change leverage?

Management should assess the debt that will remain after the proposed repayments and the effect on interest obligations and projected leverage.

3. What new funding will expansion require?

A capital expenditure programme can create additional cash requirements beyond the initial investment.

These should be considered alongside the proposed fundraising.

4. Are projected cash flows consistent with the investment plan?

The business case should account for the timing of commissioning, capacity utilisation, sales and collections rather than relying only on long-term growth expectations.

5. What risks could affect the financial projections?

Customer concentration, supplier dependence, operating disruptions and other business risks can affect revenue and cash generation.

Understanding these risks is important when evaluating the company's ability to service debt after the transaction.

What does SEBI's observation mean?

SEBI's observations allow a company to move forward with the IPO process, subject to applicable requirements.

They should not be interpreted as an endorsement of the company's valuation, a guarantee of investor demand or confirmation of a particular listing outcome.

The final transaction remains subject to the relevant regulatory requirements, disclosures and market conditions.

For companies preparing to enter the public markets, this is another reason to maintain consistency between their fundraising plans, financial disclosures and underlying business position.

The credit lesson behind the IPO

An IPO can change a company's capital structure, but the impact depends on the composition and use of the proceeds.

Fresh equity used to repay debt may reduce financial obligations. Equity used for expansion may support future growth but create near-term investment and execution requirements. An OFS may change the shareholder base without providing the same direct balance-sheet benefit to the issuer.

These are different financial outcomes, even when they appear within the same transaction.

Conclusion

Swara Baby's proposed ₹1,000 crore IPO demonstrates why companies and analysts should look beyond the headline issue size.

The more useful analysis begins with the split between fresh equity and OFS, followed by the proposed use of proceeds, the remaining debt burden and the funding requirements of the business.

For companies considering a major fundraise, the objective should be to understand how the transaction changes the entire financial profile, rather than focusing on the amount raised alone.

A fundraising plan is most meaningful when its effect on the company's capital structure and future cash flows is clearly understood.

Disclaimer: This article is for informational and educational purposes only and does not constitute financial, investment, legal or credit-rating advice. The proposed IPO structure and use of proceeds may change in the final offer documents. Regulatory observations do not guarantee an IPO launch, valuation, subscription or listing outcome. Credit ratings are assigned independently by SEBI-registered Credit Rating Agencies. FinMen Advisors provides preparatory and advisory support and does not issue, influence or guarantee rating outcomes.